JAZZ
Jazz Pharmaceuticals plc · Healthcare · Market cap $13.8B
Insiders sold $24.9M net in the last 90 days ·4 sellers, 0 buyers· 7 of 7 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 7, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$69.8M
reported sales (SEC code S)
Unique Insiders
11
in the rolling window
Latest filing
Oct 7, 2026
GALA RENEE D
Jazz Pharmaceuticals plc (JAZZ) has 84 SEC Form 4 filings (152 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Oct 7, 2026.
Inside the rolling window, 11 insiders at Jazz Pharmaceuticals plc reported no open-market purchases and 32 open-market sales totaling $69.8M. The most active filer is Director COZADD BRUCE C with 10 filings. Insiders have net sold $32.5M over the trailing 6 months. The most recent open-market filing is a sale of 2,000 shares by President & CEO GALA RENEE D, dated Oct 6, 2026, worth $473K.
- Industry:Biotechnology
- CEO:Renee D. Gala
- Employees:2,890
- HQ:Dublin, DU, IE
- IPO:2007-06-01
| Source | |||||||
|---|---|---|---|---|---|---|---|
| President & CEO | Sale | 2,000 | $473K | Oct 7 | -8.3% | SEC ↗ | |
| Director | Sale | 6,000 | $1.4M | Oct 5 | -10.2% | SEC ↗ | |
Patil Neena MFirst in 3 months | EVP & Chief Legal Officer | Sale | 1,200 | $289K | Sep 14 | -13.8% | SEC ↗ |
GALA RENEE DFirst filing | President & CEO | Sale | 2,000 | $486K | Sep 10 | -11.9% | SEC ↗ |
| Director | Sale | 6,000 | $1.5M | Sep 2 | -13.7% | SEC ↗ | |
Iannone RobertFirst in 10 months | EVP, Global Head of R&D & CMO | Sale | 76,921 | $19.2M | Aug 31 | -15.4% | SEC ↗ |
| Director | Sale | 6,000 | $1.5M | Aug 5 | — | SEC ↗ | |
| Director | Sale | 6,000 | $1.4M | Jul 6 | — | SEC ↗ | |
Smith Mark DouglasFirst filing | Director | Sale | 1,157 | $267K | Jun 17 | — | SEC ↗ |
| EVP & Chief Legal Officer | Sale | 1,200 | $278K | Jun 12 | — | SEC ↗ | |
| Director | Sale | 6,000 | $1.4M | Jun 3 | — | SEC ↗ | |
Pearce SamanthaFirst filing | EVP, Chief Commercial Officer | Sale | 6,907 | $1.6M | Jun 1 | — | SEC ↗ |
Patil Neena MFirst in 3 months | EVP & Chief Legal Officer | Sale | 1,192 | $282K | Jun 1 | — | SEC ↗ |
Winningham Rick EFirst in 6 months | Director | Sale | 2,741 | $662K | May 27 | — | SEC ↗ |
McSharry Heather AnnFirst in 6 months | Director | Sale | 2,000 | $482K | May 27 | — | SEC ↗ |
| Director | Sale | 6,000 | $1.2M | May 5 | — | SEC ↗ | |
| Director | Sale | 6,000 | $1.1M | Apr 3 | — | SEC ↗ | |
| SVP, Chief Accounting Officer | Sale | 1,287 | $235K | Mar 9 | — | SEC ↗ | |
COZADD BRUCE CFirst in 3 months | Director | Sale | 6,000 | $1.1M | Mar 4 | — | SEC ↗ |
Patil Neena MFirst filing | EVP & Chief Legal Officer | Sale | 55,600 | $10.7M | Mar 2 | — | SEC ↗ |
RIEDEL NORBERT GFirst filing | Director | Sale | 3,415 | $656K | Mar 2 | — | SEC ↗ |
| SVP, Chief Accounting Officer | Sale | 1,253 | $243K | Mar 2 | — | SEC ↗ | |
| SVP, Chief Accounting Officer | Sale | 1,117 | $213K | Mar 2 | — | SEC ↗ | |
| SVP, Technical Operations | Sale | 5,343 | $1.0M | Mar 2 | — | SEC ↗ | |
Henderson Mary ElizabethFirst filing | SVP, Technical Operations | Sale | 2,238 | $379K | Dec 11 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading JAZZ 8 all-time
- DRep. Daniel GoldmanSale$15,001 - $50,0002023-07-12
- DRep. Ro KhannaSale$1,001 - $15,0002023-05-19
- DRep. Daniel GoldmanPurchase$15,001 - $50,0002023-03-06
- DRep. Ro KhannaPurchase$1,001 - $15,0002023-03-14
- DRep. Daniel GoldmanSale$1,001 - $15,0002023-01-31
- DRep. Thomas SuozziOther$1,001 - $15,0002022-09-26
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does JAZZ have?
Jazz Pharmaceuticals plc (JAZZ) has 84 SEC Form 4 filings (152 transaction rows) in the rolling 365-day window, disclosed by 11 distinct insiders. Most recent filing: Oct 7, 2026.
When was the most recent SEC Form 4 filing for JAZZ?
The most recent Form 4 filing for JAZZ on Tracefour is dated Oct 7, 2026.
Who is the most active insider at JAZZ?
The most active SEC Form 4 filer at JAZZ in the rolling window is Director COZADD BRUCE C, with 10 filings.
What is the net insider flow at JAZZ over the last 6 months?
Over the trailing 180 days, insiders at JAZZ have net sold $32.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at JAZZ in the current window?
Inside the rolling window, insiders at JAZZ bought $0 and sold $69.8M based on SEC Form 4 filings.
Can I get alerts for JAZZ insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Jazz Pharmaceuticals plc (JAZZ). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Jazz Pharmaceuticals plc is in the Healthcare sector.